Insufficient scRNA-seq data for expression of USP35 at single-cell level.
Insufficient scRNA-seq data for expression of USP35 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3799.86 | 258 / 258 | 100% | 17.39 | 229 / 230 |
esophagus | 100% | 1224.41 | 1445 / 1445 | 99% | 6.96 | 182 / 183 |
thymus | 100% | 1888.19 | 653 / 653 | 99% | 8.32 | 599 / 605 |
brain | 99% | 1176.09 | 2616 / 2642 | 100% | 9.85 | 704 / 705 |
breast | 100% | 1132.93 | 459 / 459 | 98% | 10.60 | 1093 / 1118 |
bladder | 100% | 1343.38 | 21 / 21 | 97% | 5.72 | 489 / 504 |
lung | 100% | 1455.62 | 577 / 578 | 96% | 5.79 | 1110 / 1155 |
ovary | 100% | 1508.45 | 180 / 180 | 96% | 7.83 | 412 / 430 |
pancreas | 98% | 659.17 | 321 / 328 | 98% | 6.78 | 174 / 178 |
skin | 96% | 712.57 | 1739 / 1809 | 99% | 10.06 | 468 / 472 |
uterus | 100% | 1521.51 | 170 / 170 | 95% | 5.74 | 434 / 459 |
kidney | 100% | 1112.69 | 89 / 89 | 94% | 4.53 | 845 / 901 |
intestine | 100% | 1227.29 | 964 / 966 | 92% | 4.39 | 486 / 527 |
liver | 100% | 1747.46 | 226 / 226 | 92% | 6.47 | 372 / 406 |
stomach | 96% | 759.13 | 346 / 359 | 93% | 4.48 | 265 / 286 |
prostate | 100% | 1296.86 | 244 / 245 | 87% | 3.23 | 439 / 502 |
blood vessel | 100% | 3790.17 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1020.51 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.24 | 1 / 1 |
adipose | 100% | 1233.88 | 1200 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 7.68 | 78 / 80 |
heart | 97% | 1101.77 | 832 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 648.96 | 853 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 3.92 | 40 / 45 |
muscle | 89% | 465.12 | 711 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 3.10 | 21 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0016579 | Biological process | protein deubiquitination |
GO_0005829 | Cellular component | cytosol |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | USP35 |
Protein name | Ubiquitin carboxyl-terminal hydrolase 35 (EC 3.4.19.12) (Deubiquitinating enzyme 35) (Ubiquitin thioesterase 35) (Ubiquitin-specific-processing protease 35) USP35 protein Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) Ubiquitin specific peptidase 35 |
Synonyms | USP34 KIAA1372 |
Description | FUNCTION: Deubiquitinase that plays a role in different processes including cell cycle regulation, mitophagy or endoplasmic reticulum stress . Inhibits TNFalpha-induced NF-kappa-B activation through stabilizing TNIP2 protein via deubiquitination . Plays an essential role during mitosis by deubiquitinating and thereby regulating the levels of Aurora B/AURKB protein . In addition, regulates the protein levels of other key component of the chromosomal passenger complex (CPC) such as survivin/BIRC5 or Borealin/CDCA8 by enhancing their stability . Regulates the degradation of mitochondria through the process of autophagy termed mitophagy . . FUNCTION: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes. . |
Accessions | E9PRM2 ENST00000529308.6 [Q9P2H5-1] A2RRA6 ENST00000528910.5 Q9P2H5 H0YEP1 E9PK78 ENST00000530267.5 ENST00000526425.1 [Q9P2H5-2] ENST00000530546.5 |